Cirdan
PrivateLast Round
VC Round
Apr 14, 2026
Est. Valuation
$13.14M
Total Funding Raised
$12.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cirdan operates in Healthcare & Life Sciences and is based in Lisburn. Its latest recorded funding round was a VC Round in April 2026.
Cirdan is a healthcare technology company that provides laboratory information systems (LIS) and imaging solutions to accelerate and enhance diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, EHR & EMR, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cirdan Comparables
Compare Cirdan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CrelioHealth | 83% | |
| Lumea | 82% | |
| NovoPath | 79% |
For institutional investors. Book with your work email.
Cirdan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 14, 2026 | ||||
| Growth Equity | Oct 15, 2024 | ||||
| VC Round | Oct 12, 2023 | ||||
| Debt | Feb 18, 2020 | ||||
| VC Round | Feb 4, 2016 | ||||
VC Round | Feb 23, 2015 |
For institutional investors. Book with your work email.
Cirdan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Salica Investments | VC Round |
| QUBIS | Seed |
| Kernel Capital | Growth Equity, VC Round |
| Whiterock Finance | Debt |
| British Business Bank | Debt, Growth Equity, VC Round |
| Invest Northern Ireland | Debt, Seed |
| 57 Stars | Growth Equity, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
$5M raised in a venture debt round.
- Jan 14, 2026
Platform now FHIR-ready, supporting modern healthcare integration standards.
For institutional investors. Book with your work email.
Cirdan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cirdan's valuation, stock price, and market status.
Is Cirdan a public or private company?
Cirdan is a private company.
What is the current stock price of Cirdan?
Cirdan is a private company, so its shares have no public market price. Caplight tracks Cirdan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cirdan worth (valuation)?
Cirdan's valuation is estimated at $13.1M based on funding round data.
Can I buy Cirdan stock?
Cirdan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cirdan's last funding round?
Cirdan's most recent funding round was VC Round on April 14, 2026.
Who are the main investors in Cirdan?
Key investors in Cirdan include Salica Investments, Kernel Capital, Whiterock Finance, Clarendon Fund Managers, Hambro Perks Ltd..
Will Cirdan IPO soon?
No public IPO plans have been announced for Cirdan.
How can I track Cirdan secondary market activity?
Caplight tracks bids, offers, and trades in Cirdan's shares on secondary markets.